Saraswati commercial (India) Ltd has announced that its Board of Directors will convene on February 12, 2026, to review and approve the company's quarterly financial performance. The meeting notification was submitted to BSE Limited on February 5, 2026, in compliance with regulatory requirements.

Board Meeting Agenda

The primary focus of the board meeting will be the consideration and approval of crucial financial documents for the third quarter of fiscal year 2026. The directors will review comprehensive financial data covering both quarterly and nine-month performance periods.

Financial Results Under Review

The board will examine the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. These results will be accompanied by a Limited Review Report from the company's auditor for the same period. The financial statements will provide insights into the company's operational performance and financial position during the specified timeframe.

Regulatory Compliance and Trading Window

Saraswati Commercial (India) Ltd has implemented strict compliance measures in accordance with SEBI regulations. The company has established a comprehensive framework to ensure adherence to insider trading guidelines and disclosure requirements.

Corporate Communication

The meeting notice will be made available on the company's official website at www.saraswaticommercial.com , as mandated by Regulation 46 of the SEBI Listing Regulations. This ensures transparent communication with stakeholders and maintains compliance with disclosure requirements. The company secretary and compliance officer, Avani Sanghavi, has signed the official communication to BSE Limited, confirming the meeting schedule and regulatory adherence.

Saraswati commercial (India) Limited has received trading approval from BSE Limited for 6 equity shares of Rs. 10/- each that were previously kept in abeyance. The company disclosed this development through a regulatory filing dated January 27, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Trading Approval Details

BSE Limited granted trading approval for the equity shares through its communication dated January 27, 2026. The approval enables trading members of the exchange to trade in these securities effective from Wednesday, January 28, 2026.

Share Characteristics

The approved shares were issued pursuant to a scheme and were previously kept in abeyance. These equity shares carry the same rights and privileges as the company's existing equity shares, being pari passu with the old equity shares.

Regulatory Compliance

The company fulfilled its disclosure obligations by informing BSE Limited about the trading approval receipt. Company Secretary and Compliance Officer Avani Sanghavi signed the regulatory filing, ensuring proper compliance with listing regulations.

BSE Limited issued Notice No. 20260127-14 dated January 27, 2026, to inform trading members about the listing and trading permission for these new securities. The notice categorized this development under company-related announcements in the equity segment.